Sentrx

Sentrx announces it has augmented the key performance metrics associated with its SaPh Cloud Solution with internet-based metrics that provide 24/7 mission-critical remote availability monitoring and performance measurement.

Sentrx, a provider of drug safety services to the life sciences industry announced today that Charles T. Saldarini has resigned his position as CEO and Chairman of the Board to pursue efforts with his own company, The Charles T. Saldarini Group.

TransPerfect & Sentrx announced a collaboration involving TransPerfect’s Trial Interactive Portal Technology to streamline end-to-end global drug safety capabilities in both clinical & post-marketing event management.

Sentrx, the leading provider of drug safety services to the life sciences industry, is pleased to announce the promotion of Michael O’Gorman from CFO to President & General Manager, effective immediately.